Erlotinib/gefitinibAcneiform eruption: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1441卷 / 1期

关键词：

D O I：

10.1007/s40278-013-1646-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：15 / 15

相关论文

共 50 条

[31] Nivolumab/pembrolizumabBullous pemphigoid and bullous eruption: 3 case reports
Reactions Weekly, 2017, 1673 (1) : 282 - 282
[32] PerampanelAbdominal symptoms, drug eruption and drowsiness: 3 case reports
Reactions Weekly, 2019, 1782 (1) : 259 - 259
[33] Erlotinib/gefitinibVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1829 (1) : 172 - 172
[34] Erlotinib/gemcitabineVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1704 (1) : 153 - 153
[35] Erlotinib/gefitinibSkin rashes: 4 case reports
Reactions Weekly, 2014, 1532 (1) : 92 - 92
[36] Erlotinib/gefitinibVarious toxicities: 11 case reports
Reactions Weekly, 2011, 1358 (1) : 16 - 16
[37] Erlotinib/lumretuzumabRash and diarrhoea: 2 case reports
Reactions Weekly, 2017, 1658 (1) : 188 - 188
[38] Erlotinib/gefitinibHepatotoxicity and arthritis: 2 case reports
Reactions Weekly, 2017, 1658 (1) : 187 - 187
[39] Erlotinib/gefitinibAcquired resistance: 2 case reports
Reactions Weekly, 2021, 1857 (1) : 149 - 149
[40] Erlotinib/gefitinibDermatological effects: 2 case reports
Reactions Weekly, 2012, 1429 (1) : 18 - 18

← 1 2 3 4 5 →